Innoviva Inc
NASDAQ:INVA

Watchlist Manager
Innoviva Inc Logo
Innoviva Inc
NASDAQ:INVA
Watchlist
Price: 19.3 USD -3.5% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
Innoviva Inc?
Write Note

Innoviva Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innoviva Inc
Income from Continuing Operations Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Innoviva Inc
NASDAQ:INVA
Income from Continuing Operations
$64.6m
CAGR 3-Years
-45%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Income from Continuing Operations
$14.8B
CAGR 3-Years
-6%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Income from Continuing Operations
-$7.2B
CAGR 3-Years
-10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Income from Continuing Operations
$4.3B
CAGR 3-Years
-40%
CAGR 5-Years
4%
CAGR 10-Years
-9%
Merck & Co Inc
NYSE:MRK
Income from Continuing Operations
$12.2B
CAGR 3-Years
27%
CAGR 5-Years
5%
CAGR 10-Years
8%
Eli Lilly and Co
NYSE:LLY
Income from Continuing Operations
$8.4B
CAGR 3-Years
12%
CAGR 5-Years
14%
CAGR 10-Years
12%

See Also

What is Innoviva Inc's Income from Continuing Operations?
Income from Continuing Operations
64.6m USD

Based on the financial report for Sep 30, 2024, Innoviva Inc's Income from Continuing Operations amounts to 64.6m USD.

What is Innoviva Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
-31%

Over the last year, the Income from Continuing Operations growth was 29%. The average annual Income from Continuing Operations growth rates for Innoviva Inc have been -45% over the past three years , -31% over the past five years .

Back to Top